Background The only two preparations of botulinum toxin A for which there are published
evidences of efficacy in children with cerebral palsy are onabotulinum toxin A (Botox®) and …

Abstract Background IncobotulinumtoxinA (Xeomin®) is a botulinum neurotoxin type A with
established efficacy in the treatment of upper-limb spasticity in adults. This retrospective …

The current modalities in managing spastic children have some limitations; thus, alternative
therapeutic agents are in need. The purpose of this study is to investigate whether …

BACKGROUND. Spasticity is a prevalent disabling clinical symptom for children with
cerebral palsy. Treatment of spasticity with botulinum toxin in children with cerebral palsy …

BACKGROUND For more than 20 years, intramuscular injections of botulinum toxin A have
been an established treatment for spasticity in children with cerebral palsy. We investigated …

PURPOSE: Investigate the efficacy and safety of multipattern incobotulinumtoxinA injections
in children/adolescents with lower-limb cerebral palsy (CP)-related spasticity. METHODS …

In this study, we compared the long‐term efficacy and tolerability of two dosage regimens of
the potent botulinum toxin type A (BoNT‐A; Dysport; Ipsen Ltd, Slough, UK) in children with …

Question What is the role of intramuscular botulinum toxin injections in the management of
spasticity and related morbidity in children with cerebral palsy? Answer When botulinum …

Background: Cerebral palsy (CP) is the most common cause of childhood disability globally.
Botulinum toxin A injections are widely used to manage limb spasticity in children with CP …

Aim To assess the efficacy and safety of repeat abobotulinumtoxinA injections in reducing
upper limb spasticity in children with cerebral palsy (CP). Method This was a double‐blind …